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Abstract
Background: It has been indicated that rotator cuff tears, especially large or massive ones, can cause suprascapular
neuropathy. When such a diagnosis has been established, it is still unknown whether an arthroscopic release of the
superior transverse scapular ligament during cuff repair can change the course of this neuropathy.
Methods/design: This is a single-center, double-blinded randomized controlled trial for which 42 patients with large
or massive repairable rotator cuff tears and suprascapular neuropathy will be recruited and followed up at 6 and
12 months. Nerve function will be measured by nerve conduction and electromyography studies preoperatively and at
the selected follow-up periods. Patients will be randomly divided into equally numbered groups, the first one being
the control group. Patients of this group will undergo arthroscopic repair of the rotator cuff without combined
arthroscopic release of the superior transverse scapular ligament; in the second group the ligament will be released.
The primary objective is to test the null hypothesis that arthroscopic repair of large/massive rotator cuff tears in
patients with combined suprascapular neuropathy provides equivalent outcomes to one-stage arthroscopic cuff repair
where the superior suprascapular ligament is additionally released. The secondary objective is to search for a relation
between rotator cuff tear size and degree of suprascapular nerve recovery. The tertiary objective is to demonstrate any
relation between rotator cuff muscle fatty infiltration grade and degree of suprascapular nerve function. Patients,
clinicians during follow-up clinics and the neurologist will be blinded to the type of surgery performed.
Discussion: To the best of our knowledge, we are unaware of any prospective, randomized double-blinded studies
with similar objectives. So far, the evidence suggests a positive correlation between massive rotator cuff tears and
suprascapular neuropathy. However, there is mixed evidence suggesting that neuropathy can be effectively treated
with rotator cuff repair with or without release of the superior transverse scapular ligament.
Trial registration: ClinicalTrials.gov registration number NCT02318381; date of initial release: 5 December 2014.
Keywords: Rotator cuff tear, Suprascapular neuropathy, Arthroscopy, Superior transverse scapular ligament release, Massive
Background
Suprascapular nerve (SSN) neuropathy may be associated
with a rotator cuff tear [1], especially tears bigger than
3 cm. Cofield classified rotator cuff tears as: small tear
<1 cm, medium 1–3 cm, large 3–5 cm, and massive >5 cm
[2]. The proposed mechanism involves nerve traction that
is caused by tethering of the nerve against fixed location
points; these are the major and minor scapular notches [3].
Radiographic methods, especially computed tomography
(CT) and magnetic resonance imaging (MRI), are often
used to evaluate atrophy of the rotator cuff. Fatty infiltra-
tion and atrophy may both be associated with a torn rotator
cuff and SSN neuropathy [4–6].
Previous studies have reported a relation between SSN
neuropathy and rotator cuff tears [7–10]. If these find-
ings are proven accurate, they may represent an import-
ant step in optimizing treatment for rotator cuff tears.
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Nondiagnosed SSN neuropathy could affect the success
rate repair of the cuff and further weaken the muscles
innervated by this nerve. Theoretically, this neuropathy
may be a contributing factor in the pathophysiological
mechanism of fatty infiltration and, finally, cuff tear
arthropathy although a linear relationship between the
degree of neuropathy and the size of the rotator cuff tear
has not been demonstrated [9].
Surgical techniques of treating SSN neuropathy in the
setting of rotator cuff tears may include open or arthro-
scopic release nerve release. Open nerve release has pro-
vided good results in patients with SSN neuropathy by
improving motor function of the rotator cuff muscles [11].
However, arthroscopic release techniques are currently
gaining popularity as they can be combined with repair of
the torn rotator cuff. They are also less invasive, provide
better visualization and require less surgical time [1].
We searched the websites of online trial registries,
“http://www.clinicaltrials.gov/,” “http://www.isrctn.com,”
“http://onlinelibrary.wiley.com/cochranelibrary,” as well
as “http://www.ncbi.nlm.nih.gov/pubmed.” To the best
of our knowledge, there are no randomized prospective
studies that compare the outcome of SSN neuropathy
after arthroscopic dissection of the transverse scapular
ligament in patients with a torn rotator cuff against con-
trol groups that did not undergo ligament dissection.
We are also unaware of any studies that aimed to find any
relation between the degree of neuropathy and the size of
the rotator cuff tear. The primary objective is to test the
null hypothesis that arthroscopic repair of large/massive
rotator cuff tears in patients with combined suprascapular
neuropathy provides equivalent outcomes to one-stage
arthroscopic cuff repair where the superior suprascapular
ligament is additionally released. The secondary objective
is to search for a relation between rotator cuff tear size
and degree of SSN recovery. The tertiary objective is to
demonstrate any relation between rotator cuff muscle fatty
infiltration grade and degree of SSN function.
Methods/design
This study will be a single-center, double-blinded ran-
domized controlled trial (RCT). The trial is registered at
the ClinicalTrial.gov website, number NCT02318381.
The Institutional Review Board of “Georgios Papaniko-
laou” Hospital has provided ethical approval. The study
will be conducted in accordance with the Helsinki Dec-
laration. All patients will be provided with a written
Consent Form that they will have to sign in order to be
considered for this study. The study’s Consolidated Stan-
dards of Reporting Trials (CONSORT) flowchart and
Standard Protocol Items: Recommendations For Inter-
ventional Trials (SPIRIT) figure can be found in Fig. 1
and Table 1, respectively. The SPIRIT checklist has been
added as Additional file 1 to this protocol.
Trial objectives/endpoints
The primary endpoint of this study will be recording of
changes of function of the SSN, as assessed by electro-
myography (EMG) and/or nerve conduction (NC)
studies, preoperatively, and at 6 and 12 months postop-
eratively. All NC/EMG studies, pre and postoperative,
will be performed by one neurologist for all included pa-
tients. Clinical signs of full recovery will also be assessed
and compared pre and postoperatively.
Abnormal function of the SSN in EMG studies will be
indicated by fibrillation and high-frequency discharge
potentials. An abnormal NC assessment finding is de-
fined according to the following values: infraspinatus la-
tency >4.5 ms and an amplitude <8 mV from peak to
peak and supraspinatus muscle latency >3.5 ms and an
amplitude <8 mV from peak to peak [12]. The contralat-
eral nerve will also be examined. Abnormal findings are
also indicated when the difference in amplitude com-
pared to the healthy side is more than 50%. According
to patients’ results, the NC/EMG studies postoperatively
will show full recovery of the nerve if all parameters are
normal and partial recovery if the tested parameters are
improved but not normalized. It is possible, due to some
patients’ habitus and size, that NC studies may not be
feasible to perform on these patients. In these cases,
diagnosis will be established by EMG studies.
The secondary endpoint will be analyzing for possible
correlations between tear size, SSN neuropathy fre-
quency, and degree of postoperative nerve recovery. The
diameter of the tear will be measured preoperatively
with a ruler by using standardized MRI sagittal images.
Measurement starts at the insertion of the tendon into
the major tuberosity and ends at the most lateral margin
of the torn rotator cuff. Only the largest measured diam-
eter of the tear as found on images will be recorded.
The tertiary endpoint will be analyzing the rotator cuff
muscles for changes of fatty infiltration as assessed using
MRI studies (according to Goutallier’s classification) be-
fore and 12 months after the operation [13]. Goutallier
classified fatty infiltration as: stage 0, normal muscle;
stage 1, some fatty streaks; stage 2, less than 50% fatty
muscle atrophy; stage 3, 50% fatty muscle atrophy; stage 4,
greater than 50% fatty muscle atrophy.
Study population
Forty-two patients with SSN neuropathy and repairable
large or massive rotator cuff tears will be recruited ac-
cording to the inclusion/exclusion criteria of this RCT,
divided in two equally numbered groups and treated
within a 24-month period at the First Orthopedic
Department of Aristotle University of Thessaloniki,
“Georgios Papanikolaou” Hospital, Greece. Inclusion cri-
teria are: patients with large or massive repairable rota-
tor cuff tears combined with SSN neuropathy on the
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ipsilateral side. Exclusion criteria are: SSN neuropathy of
another cause (e.g., brachial plexus neuropathy), other
previous surgery performed on the same affected shoul-
der, and moderate to severe degenerative changes to the
ipsilateral glenohumeral joint (rotator cuff arthropathy).
All patients seen in our institution’s shoulder clinic
with MRI-confirmed large or massive repairable rotator
cuff tears and suspected SSN neuropathy will undergo
NC/EMG studies in order to establish a diagnosis of the
neuropathy. Patients with no signs of pain, atrophy, or
paresthesia over the SSN distribution area, or patients
who refuse to have any more diagnostic processes, will
not have NC/EMG studies and will not be considered
for the study. If the above studies are positive for SSN
neuropathy, and the patients meet the inclusion and
none of the exclusion criteria, they will be informed
about this trial. If they agree to participate in this trial
and sign and date the informed consent, then a further
preoperative appointment will be given.
An investigator will clinically examine the patients on
the second preoperative appointment. A specific form
will be created for each one that will contain demo-
graphic, preoperative, and postoperative data (Additional
file 2: Table S1). All patient forms will additionally be
kept in electronic records for easier data analysis.
Randomization and allocation of patients to a specific
group will be done by the statistician. All patients, the
clinical preoperative and follow-up examiner, and the
neurologist performing the NC/EMG studies will be
blinded to the type of surgery performed.
The first group of this trial will be the control group
and will consist of 21 patients; these will undergo
arthroscopic repair of the rotator cuff tear. The second
group will also consist of 21 patients. They will undergo
the procedure as above, along with an arthroscopic re-
lease of the SSN at the same stage.
Details of preoperative and postoperative examinations
All patients’ demographic data (age, gender, occupation,
allergies, smoking status, alcohol consumption) and
medical history will be recorded preoperatively. Patients
will be examined for specific clinical signs such as
Fig. 1 Study flowchart
Sachinis et al. Trials  (2016) 17:554 Page 3 of 9
Hornblower’s sign, the dropping sign, Jobe’s test,
Hawkins test, and the lag sign. Shoulder range of motion
(ROM) and shoulder power of the rotator cuff muscles
of both arms will also be examined.
The Constant-Murley [14], Disabilities of the Arm,
Shoulder and Hand (DASH) [15], and American Shoulder
and Elbow Surgeons (ASES) [16] scores will be recorded.
The Constant-Murley shoulder score has a 100-point scale
and is a commonly used outcome measure for assessing
the outcomes of the treatment of shoulder disorders. It in-
cludes a pain score, functional assessment, and ROM and
strength measures (0 worst score, 100 best score). The
DASH outcome measure has 30 questions, which are
scored from 1 to 5 according to the severity of a patient’s
symptoms (0 best score, 100 worst score). The optional
modules of this score will not be measured as, according
to our previous experience, most patients will not be pro-
fessional athletes, musicians, or high-demand workers.
Also, this will facilitate an easier comparison of scores be-
tween patients. The ASES score is another patient-
reported questionnaire and has 17 questions. The first
seven of these explore the intensity and type of pain up to
a total of 50 points and the rest measure functionality of
the shoulder and add another 50 points (0 worst score,
100 best score).
Study procedure
Patients will be randomized on the admission day and
allocated to a group, so that they may undergo arthro-
scopic rotator cuff repair alone, or combined with
arthroscopic release of the SSN. Only the operating sur-
geon, who will be the same for all patients, will be aware
of the randomization results and patient allocation list.
All patients are going to be treated according to the
established institutional protocol and the operation will
follow well-defined standards in order to minimize ad-
verse factors. All operations will be done with the pa-
tient in a beach-chair position, under general anesthesia
and with a regional (interscalene) anesthetic block for
postoperative analgesia. If general anesthesia is contrain-
dicated, then the procedure will be done with the patient
awake or mildly sedated and with the regional block as
the main anesthetic agent; these patients will be re-
corded. Prepping will be done as per hospital protocol
with aqueous povidone iodine 7.5%, and draping will be
the same for all patients. Standard portals will be made
for all patients: posterior, anterior, lateral, and anterolat-
eral; a superior portal will additionally be made for pa-
tients undergoing release of the superior transverse
scapular ligament.
The procedure will aim at fully restoring the rotator
cuff to its anatomical footprint. When the cuff is not re-
pairable then these patients will be excluded from the
study. If during the operation the surgeon fails to fully
repair the cuff and achieves only a partial repair, these
patients will be recorded and followed up but separated
from the cohort; their outcomes will be compared with
those of the rest. All repairs will be done using a trans-
osseous equivalent technique with peek anchors, knotted
medially and knotless laterally. Arthroscopic release will
Table 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) diagram
Study period
Enrollment Allocation Post allocation









Control group: repair of rotator cuff only X
Second group: repair of rotator cuff and SSN release X
Assessments:
NC/EMG studies X X X
Clinical shoulder assessment/signs X X X X
Constant-Murley score X X X
DASH score X X X
ASES score X X X
MRI scan X X
ASES American Shoulder and Elbow Surgeons, DASH Disabilities of the Arm, Shoulder and Hand, EMG electromyography, MRI magnetic resonance imaging, NC
nerve conduction, SSN suprascapular nerve
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follow the technique published by Lafosse et al. [1].
Visualization will be done mostly by the lateral portal
and the shaver will mostly work through a lateral-
anterolateral portal. The transverse ligament will be dis-
sected via a superior portal, which is created under dir-
ect vision and uses a needle to identify the exact
location of the portal.
As per the surgical protocol, all patients will also
undergo tenotomy of the long head of biceps and acro-
mioplasty with excision of the coracoacromial ligament.
Also, excision of the acromioclavicular joint will be per-
formed only if patients complain of pain in that region
along with degenerative changes being shown on X-rays,
or found intraoperatively. If any further lesions are de-
tected during the operation, the surgeon will proceed to
repair them and such incidents will also be recorded.
Skin closure will be performed with 3.0 nylon sutures.
Nonadhesive dressings and pressure dressings will be ap-
plied to the top of the shoulder and patients will be
placed in a 30o abduction sling immediately after com-
pletion of surgery.
Patients will stay overnight at the hospital. Physiother-
apists will advise them as per the physiotherapeutic
protocol (Table 2). The abduction sling will remain for
the first 6 weeks. Sutures will be removed 10 days after
surgery. Outpatient and physiotherapy clinic follow-up
will be arranged at 6 weeks, 3 months, and 6 and
12 months postoperatively. Neurology clinics for NC/
EMG studies will be arranged at 6 and 12 months post-
operatively. Outcome scores will be collected at 6 and
12 months after surgery.
Procedure risks/complications
Releasing the superior transverse scapular ligament car-
ries the risk of damage to the SSN and artery. Normally,
the nerve lies inferior to the ligament and medially is
protected by the shaver during soft-tissue resection. The
artery, however, passes superior to the ligament and is
potentially in jeopardy. Care will be taken not to cut the
artery. However, if it is injured, coagulation may be
achieved by using a radiofrequency device. No additional
morbidity has been observed in such cases due to the
rich collateral circulation of this region. Patients will be
informed of these risks before signing the Consent
Form.
Trial duration
The main trial period will start 6 weeks prior to surgery
(where clinical NC/EMG and MRI evaluation will be
done) and will include the operative intervention and
the postoperative period up to the last follow-up.
Follow-up clinical examinations and NC/EMG studies
for all patients will be conducted at 6 and 12 months
after surgery. MRI studies for each patient will be done
at least 1 year after the date of the operation.
With a recruitment period of 24 months and a follow-
up period of 12 months, the total length of this study is
expected to be approximately 36 months. This trial will
end when all the necessary 42 patients have completed it.
Also, the principal investigators may decide to terminate
the study at any time for any reasonable or medical
reasons. The final report of this trial will follow the
Table 2 Brief physiotherapy protocol for postoperative rehabilitation of repaired large/massive rotator cuff tears
Time Focus Range of motion Recommended exercises Precautions
0–6 weeks Tissue healing No passive assisted or active
ROM of shoulder allowed
apart from table slides
• Restricted table slides after
2nd week to 30°
• AROM of elbow, wrist, hand
• No active reaching
• Sling at all times
6–12 weeks PROM, AAROM with transition
to AROM
Regain full PROM and AAROM,
transition to AROM at
10 weeks
• PROM of shoulder,
pendulums, scapular mobility,
ball squeeze begin AAROM at
8 weeks
• Isometrics and active
progression at 10 weeks
• No resisted activity and lifting
• Avoid overloading of
supraspinatus
• Must regain scapular rhythm
before transition to
strengthening
12–24 weeks AROM and progressive
strengthening
Regain full AROM • Continue PROM and AAROM
as needed
• Initiate strengthening and
progress AROM to functional
planes
• Progress proprioceptive drills,
rhythmic stabilization, push-
ups, resistance band
• No heavy or repetitive
overhead activities
• Limited return to gym after
20th week if AROM with
satisfactory scapular rhythm
has been achieved
• Free full ROM
24 weeks–1 year Return to sports and physical
activity if ROM and strength
adequate
• Progression of strengthening
• Continue resistance band,
proprioceptive drills and
periscapular stabilization until
full return to physical activity
and sports
• Return to sports
• Progress gym lifting
AAROM active assisted range of motion, AROM active range of motion, PROM passive range of motion, ROM range of motion
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Statistical analysis of previous relevant medical literature
was used in order to identify the number of patients
needed for this trial. Since no similar studies could be
found, we searched for results from similar articles rela-
tive to the trial. Costouros et al. [7] treated six patients
with massive rotator cuff tears and SSN neuropathy by
arthroscopically repairing the cuff. They found complete
nerve recovery in four out of six patients. Oizumi et al.
[17] performed an arthroscopic release in 18 patients
with a rotator cuff tear and all had complete recovery
from SSN palsy, although the diagnosis was clinical and
no NC/EMG studies were done. Lafosse et al. [1] men-
tion unpublished data of 29 massive rotator cuff tear
cases accompanied by SSN neuropathy, where no statis-
tical difference was found between patients who under-
went nerve release and patients who did not; however,
no further data or tables are provided and the cases are
anecdotal. Therefore, we considered that 100% of pa-
tients undergoing nerve release and 66.67% of patients
undergoing rotator cuff repair only could have full nerve
recovery.
We used the statistical program G*Power [18] in order
to do a priori power analysis of the primary endpoint of
this study. By using a Fisher’s exact test to compute dif-
ferences between these groups, a 100% success probabil-
ity of the first group (nerve release) and a 66.67%
probability of the second group, a error probability set at
0.05, power set at 0.8, and an allocation ratio equal to 1,
a total of 38 patients were found to be needed, 19 for
each group. Usually, patients who undergo such opera-
tions rarely miss standard follow-ups in this institution
because these are part of their physiotherapy and clinical
postoperative care (apart from the NC/EMG studies). If
10% of recruited patients fail to attend follow-ups for
any reason, then 42 patients will be required for this
RCT.
Statistical methods
Statistical analysis will be carried out after all patients
have completed 12 months of follow-up. Fisher’s exact
test will be used for the primary endpoint of the trial. In
order to analyze secondary endpoints, the type of data
distribution will be studied. If the results follow a normal
distribution, the chi-square test and t test will be used to
compare qualitative and quantitative parameters accord-
ingly. If the results do not follow a normal distribution,
quantitative parameters will be studied with the Mann-
Whitney test. Depending on the data collected, further
tests, such as the Wilcoxon and Kruskal-Wallis tests,
may be done for subgroups. Statistical differences will be
considered significant if P < 0.05.
Randomization/blinding
The choice of resecting or not the transverse scapular
ligament will be done in a randomized manner.
Randomization will be made by using the Microsoft Of-
fice Excel program and its RAND function. Forty-two
cells will be created and the numbers in them will be
rounded up so that they have no decimals. Odd numbers
will create the first group and even numbers will create
the second group. If RAND function fails to create even
groups, it will be redone until even groups of odd and
even numbers are achieved. Patients will be placed at
each consecutive cell at the time of recruitment, after in-
clusion in this trial, and will be randomized by the statis-
tician. The surgeon will be informed about the type of
treatment needed for patients on the admission day.
This will be facilitated with opaque envelopes containing
the patient’s group, which the primary investigator will
have received from the statistician. The primary investi-
gator will place this envelope inside the patient’s physical
records just before the patient is taken to the operating
room. An operating department practitioner nurse will
open the envelope just after the surgeon finishes the ro-
tator cuff repair and will instruct him, according to the
patient’s group, whether to release the ligament or not.
By doing this, the surgeon will not be biased by knowing
the patient’s group before repairing the cuff (avoidance
of performance bias).
The surgeon, therefore, clearly cannot be blinded to
the type of procedure, but this will not bring any bias to
the study. Patients, physiotherapists, and the clinician
measuring outcomes will be blinded to each patient’s al-
located treatment. The neurologist will also not know
the type of surgery performed. This blinding will assist
in obtaining objective results while performing NC/
EMG studies and should exclude such bias.
Subject withdrawal
Patients may withdraw from the study at several stages
of the trial, if they wish it, even after having signed the
Consent Form. They may also reject an intervention or
reject a follow-up evaluation. If patients reject the oper-
ation, then they will be excluded from the study. If they
reject a follow-up evaluation, then their data will be ana-
lyzed and individually reported at the final report of this
trial, irrespective of their group. During surgery, if mod-
erate or severe rotator cuff arthropathy is found, or if
the surgeon fails to repair the cuff or release the SSN,
then patients will be withdrawn from the trial. Postoper-
atively, patients may be removed from the RCT if they
deteriorate and a diagnosis of rotator cuff re-rupture is
made by ultrasound or MRI studies.
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Discussion
Published studies have demonstrated a relation between
SSN neuropathy and large/massive retracted rotator cuff
tears [8, 9]. Mallon et al. analyzed the outcomes of eight
patients with SSN neuropathy and a massive retracted
rotator cuff tear. All these patients also presented with
SSN neuropathy that was confirmed by EMG studies.
Four of these patients underwent partial repair of the
cuff. Two of them showed re-innervation potentials [8].
In the Shi et al. study, 87 patients underwent NC/EMG
studies and MRI of their symptomatic shoulder. The
study concluded that an exact relation between SSN
neuropathy and rotator cuff pathology remains unclear
and found that SSN neuropathy is associated with ten-
don tear size. However, this relation was not linear as
minimally retracted tears were more strongly correlated
with SSN neuropathy when compared to bigger ones.
This study aims to better define that relationship and to
discover the most effective treatment for this disease. If
both interventions performed in this trial have the same
potential in reversing SSN neuropathy, then there will
be no need to release the SSN when dealing with SSN
neuropathy in the setting of large/massive rotator cuff
tears. Just by repairing the tendon and, therefore, the
length of the muscle/tendon unit, the nerve will be freed
and have potential for re-innervation.
Experimental studies have revealed a possible relation
between the size of rotator cuff tear and degree of nerve
damage. Warner et al., in their cadaveric study, deter-
mined that lateral reduction of rotator cuff tears of more
than 3 cm might result in significant tension on the SSN
and entrapment as the nerve passes through the trans-
verse scapular ligament [19]. Greiner et al., in another
cadaveric study, found that that the maximum lateral ad-
vancement of a retracted rotator cuff tear is between 1
and 3 cm. As advancement progresses, the neurovascu-
lar pedicle is placed under increased tension [20]. How-
ever, Hoellrich et al. did EMG studies and did not find
any SSN neuropathy after repairs of massive rotator cuff
tears in nine patients (mean advancement of 2.5 cm,
range 2.0 to 3.5 cm). They concluded that the tendons
could be mobilized and advanced up to 3.5 cm without
putting the SSN at risk [21]. Although studies suggest
nerve damage even after small traction, the medical lit-
erature has shifted towards finding a relation between
SSN neuropathy and massive rotator cuff tears (more
than a 5-cm tendon gap).
Electromyography studies are generally considered in
patients with unexplained shoulder pain, but his has
been debated as authors disagree about the sensitivity
and specificity of EMG [22–24]. A damaged nerve can
produce several abnormal findings on an EMG, such as
reduced amplitude of motor potentials, increased spon-
taneous activity, fibrillations, polyphasic activity, and
fibrillation and sharp waves. The accuracy of NC/EMG
studies in assessing SSN neuropathy has been chal-
lenged, as there are no clear criteria [12]. Diagnosing
SSN neuropathy in patients with massive rotator cuff
tears can be even more difficult, especially clinically, as
the symptoms between these entities overlap. Due to the
lack of any other validated foolproof test, however, NC/
EMG studies have become the “gold standard” [12].
It has been impossible so far to validate NC/EMG
studies in patients with rotator cuff tears. Muscle biopsy
or neural cell adhesion molecule histochemistry can in-
dicate denervated muscle as shown in experimental
models. However, its accuracy fails in the setting of a
tenotomized muscle [25], which also affects EMG stud-
ies [26]. Thus, no trials have previously validated NC/
EMG studies for the diagnosis of SSN neuropathy in the
setting of large/massive rotator cuff tear, nor have they
defined concise diagnostic criteria. Colin et al., in an at-
tempt to define the prevalence of suprascapular neur-
opathy with repairable massive rotator cuff tears in 49
patients below 65 years of age, documented the diagnos-
tic criteria that they used when performing NC/EMG
studies [12]. Interestingly, they found a low relation (2%)
between SSN neuropathy and massive rotator cuff tears.
Techniques used in order to perform SSN release can be
open or arthroscopic. Open SSN release has provided good
results in a series of 39 patients; 28 showed improvement
of supraspinatus muscle strength to grade 4 [11]. However,
arthroscopic techniques have gained momentum, possibly
due to being less invasive, having better visualization and
having the ability to be combined with repair of the rotator
cuff without the need for extra incisions.
The technique of arthroscopic transverse scapular liga-
ment dissection has been described previously [1, 27–29].
Lafosse et al. in 2007 reported excellent outcomes in
nine out of ten patients who underwent SSN arthro-
scopic decompression without rotator cuff repair [28].
Complete normalization of latency in NC/EMG studies
was found in seven of these patients. Costouros et al.
reported six patients with SSN neuropathy related to
massive cuff tear. He found complete improvement in
EMG function in four and partial recovery in two pa-
tients [7]. In a study by Shah et al., 21/24 (87.5%) pa-
tients had deep posterior shoulder pain and NC/EMG
findings of SSN denervation. After SSN decompres-
sion, 17/24 (71%) of these patients had reduced levels
of pain at 9 weeks after surgery and demonstrated im-
proved ASES scores [30]. The authors also hypothe-
sized that there may be a subgroup of patients with
negative NC/EMG studies presenting with unexplained
posterior shoulder pain and that these patients may re-
spond to SSN decompression.
The studies above show promising results after release of
the SSN, but reversal of muscle atrophy is not always
Sachinis et al. Trials  (2016) 17:554 Page 7 of 9
observed. Kim et al. reported 90% of patients with profound
muscle weakness regaining supraspinatus muscle strength
to grade 4 or better, but infraspinatus muscle strength gains
were less predictable [11]. Fabre et al. reported 89% of pa-
tients obtaining good-to-excellent outcome after open SSN
decompression, but reversal of muscle atrophy was only
seen in half of these patients (52%) [31].
In conclusion, published studies so far deliver some
evidence regarding the relation between SSN and
massive cuff tears and suggest good/excellent postopera-
tive outcomes, with or without releasing the SSN. These
cohort studies provide ultimately inconsistent and am-
bivalent results, as they do not measure their current
management with an alternate treatment. The need for
comparable studies becomes apparent in order to create
a guideline, which would assist shoulder surgeons in
making effective and safe treatment choices when deal-
ing with patients with repairable large/massive rotator
cuff tears and SSN neuropathy.
Trial status
The study is currently in its recruiting phase.
Additional files
Additional file 1: SPIRIT checklist: recommended items to address in a
clinical trial protocol and related documents*. (PDF 499 kb)
Additional file 2: Table S1. Patient forms which will contain
preoperative and postoperative clinical signs and brief outcomes of
neurophysiological and imaging studies. (PDF 667 kb)
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